India is considering a proposal to hike costs of obtaining blood via tranfusion by up to 70% as part of a plan to revise service charges to help pay for more advanced testing and storage of blood.
Nicholas Piramal (NPIL) has reportedly signed a research deal potentially worth a maximum revenue of USD 350 million with US pharmaceutical giant Merck & Co to carry out early discovery and development of two new cancer drugs, the two companies said on Monday.
Mumbai-based Wockhardt Hospitals is planning to set up 14 super-speciality hospitals across the country over the next two years, which could entail an investment of up to INR 600 crore.
